YU103A - Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju - Google Patents
Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidacijuInfo
- Publication number
- YU103A YU103A YU103A YUP103A YU103A YU 103 A YU103 A YU 103A YU 103 A YU103 A YU 103A YU P103 A YUP103 A YU P103A YU 103 A YU103 A YU 103A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- ppm
- inert gas
- aqueous formulations
- obtaining
- priciples
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0005—Degasification of liquids with one or more auxiliary substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Removal Of Specific Substances (AREA)
Abstract
Predmetni pronalazak spada u oblast organske hemije, konkretnije u oblast terapeutske hemije. Preciznije, on se odnosi na postupak za dobijanje vodenih formulacija aktivnih sastojaka koji lako oksidišu, posebno fenola, koji su stabilni tokom dužeg vremenskog perioda, pri čemu postupak obuhvata deoksigenizaciju produvavanjem mehurićima inertnog gasa i/ili vakuumizacijom rastvora, uz istovremenu zaštitu od dejstva kiseonika na taj način što se rastvor drži u atmosferi inertnog gasa, putem punjenja boca sa rastvorom u atmosferi inertnog gasa, pri čemu je iz boca prethodno izbačen vazduh putem produvavanja inertnim gasom, nakon čega se zatvorene boce izlažu vakuumu, pri čemu se postiže pritisak u bocama ne veći od 65 000 Pa, čime se dobijaju rastvorene supstance sa koncentracijama rezidualnog kiseonika u rastvoru, manjem od 2 ppm, a poželjno reda 1 ppm i čak 0,5 ppm. Predmetni pronalazak je posebno koristan za pripremanje injektibilnih preparata koji imaju sadržaj kiseonika u rastvoru manji od 2 ppm.$The invention concerns the field of organic chemistry and more particularly that of therapeutic chemistry. More precisely, it concerns a method for obtaining aqueous formulations of easily oxidizable active principles, in particular phenols, stable over a prolonged period, which consists in advanced bubbling deoxygenation with an inert gas and/or vacuumizing them, while protecting them against possible oxygen uptake by maintaining them under inert gas atmosphere, by filling under inert gas into bottles previously made air-free by inert gas blowing, then in subjecting them when they are being closed to a vacuum so as to obtain in the bottle a pressure of not more than 65.000 Pa, thereby obtaining solutes having a residual oxygen concentration in the solution, less than 2 ppm, and preferably of the order of 1 ppm and even 0.5 ppm. The invention is useful in particular for preparing injection preparations having an oxygen content in the solution, less than 2 ppm.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007231A FR2809619B1 (fr) | 2000-06-06 | 2000-06-06 | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
Publications (1)
Publication Number | Publication Date |
---|---|
YU103A true YU103A (sh) | 2006-05-25 |
Family
ID=8851012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU103A YU103A (sh) | 2000-06-06 | 2001-06-06 | Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju |
Country Status (16)
Country | Link |
---|---|
US (1) | US6992218B2 (xx) |
CN (1) | CN1556694A (xx) |
AP (1) | AP1880A (xx) |
AU (1) | AU2001266120A1 (xx) |
CA (1) | CA2415403C (xx) |
CZ (1) | CZ200313A3 (xx) |
DZ (1) | DZ3384A1 (xx) |
FR (1) | FR2809619B1 (xx) |
MA (1) | MA26926A1 (xx) |
MX (1) | MXPA03000001A (xx) |
NZ (1) | NZ523458A (xx) |
PE (1) | PE20030508A1 (xx) |
RU (1) | RU2003100090A (xx) |
TW (1) | TWI237570B (xx) |
WO (1) | WO2001093830A1 (xx) |
YU (1) | YU103A (xx) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
ITMI20012135A1 (it) | 2001-10-16 | 2003-04-16 | Bioren S A | Soluzioni iniettabili pronte all'uso di paracetamolo |
FR2832063B1 (fr) * | 2001-11-15 | 2004-08-27 | Aguettant Lab | Procede de production de solutions stables de substances phenoliques et les solutions en resultant |
FR2851164B1 (fr) * | 2003-02-14 | 2005-04-22 | Xuan Tho Nguyen | Formulation liquide injectable de paracetamol |
US20050020554A1 (en) * | 2003-06-06 | 2005-01-27 | Ahmed Salah U. | Stability of hormone formulations |
FR2880807B1 (fr) * | 2005-01-19 | 2007-04-13 | Aguettant Sa Lab | Composition pharmaceutique injectable |
BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
DE102005037653A1 (de) * | 2005-08-05 | 2007-02-15 | Theraselect Gmbh | Stabile, flüssige Formulierung von Paracetamol |
US20070077303A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for providing oxidatively stable ophthalmic compositions |
FR2894154B1 (fr) * | 2005-12-06 | 2008-03-14 | Pharmatop Scr | Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation. |
CA2635797C (en) * | 2006-02-09 | 2015-03-31 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
WO2007112052A2 (en) | 2006-03-23 | 2007-10-04 | Macusight, Inc. | Formulations and methods for vascular permeability-related diseases or conditions |
US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
AU2006346318B2 (en) | 2006-07-18 | 2011-02-10 | Genfarma Laboratorio S.L. | Injectable liquid paracetamol formulation |
EP1992334A1 (en) * | 2007-05-08 | 2008-11-19 | Docpharma NV/SA | Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation |
DE102007026975A1 (de) * | 2007-06-01 | 2008-12-04 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Antioxidationsmittel für Lebensmittel |
AR067048A1 (es) * | 2007-06-18 | 2009-09-30 | Combino Pharm Sl | Formulaciones acuosas de acetaminofen para inyeccion. |
WO2009081283A2 (en) * | 2007-06-18 | 2009-07-02 | Combino Pharm, S.L. | Aqueous formulations of acetaminophen for injection |
WO2009064928A1 (en) | 2007-11-13 | 2009-05-22 | Cadence Pharmaceuticals | Reduced dose intravenous acetaminophen |
EP2307056B1 (en) * | 2008-01-17 | 2021-12-15 | Pharmis Biofarmacêutica, LDA | Stabilized aqueous formulation containing paracetamol |
FR2926992B1 (fr) * | 2008-02-06 | 2011-01-14 | Moly Pharma | Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution |
ES2638012T3 (es) * | 2008-06-11 | 2017-10-18 | Südzucker AG Mannheim/Ochsenfurt | Uso de trehalulosa como antioxidante de alta eficacia |
EP2243477A1 (de) | 2009-04-22 | 2010-10-27 | Fresenius Kabi Deutschland GmbH | Paracetamol zur parenteralen Verabreichung |
US8404748B2 (en) | 2009-08-13 | 2013-03-26 | Neogen N.V. | Storage-stable formulation of paracetamol in aqueous solution |
EP2464332B1 (en) | 2009-08-13 | 2016-03-02 | Neogen N.V. | Storage-stable formulation of paracetamol in aqueous solution |
CN102548639B (zh) * | 2009-09-24 | 2015-04-29 | 株式会社东芝 | 二氧化碳吸收液 |
CN102711726A (zh) | 2009-12-10 | 2012-10-03 | 特克尼梅德医疗技术股份公司 | 用于制备扑热息痛稳定液体制剂的方法和组合物 |
US20110207824A1 (en) * | 2010-02-25 | 2011-08-25 | Moly Pharma | Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution |
JP2014505081A (ja) * | 2011-02-10 | 2014-02-27 | ネオジャン,エヌ.ヴェー. | 貯蔵安定性のある水溶液中のパラセタモール配合物 |
SI3287123T1 (sl) | 2011-03-04 | 2020-07-31 | Gruenenthal Gmbh | Vodna farmacevtska formulacija tapentadola za peroralno uporabo |
ES2414557B1 (es) * | 2012-01-16 | 2014-06-10 | Novocat Farma, S.A. | Composición acuosa de paracetamol para inyección |
ITMI20121154A1 (it) | 2012-06-29 | 2013-12-30 | Sint Sa | Soluzione iniettabile di acetaminofene per la somministrazione spinale |
CN103006550A (zh) * | 2012-12-11 | 2013-04-03 | 哈药集团三精制药股份有限公司 | 一种胞磷胆碱钠注射液及其制备方法 |
US20140303254A1 (en) * | 2013-04-08 | 2014-10-09 | InnoPharma Licensing LLC | Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation |
UY35988A (es) * | 2014-02-27 | 2015-09-30 | Sint Sa | Proceso para la producción de una solución inyectable de noradrenalina de baja concentración |
BR102014005885B1 (pt) | 2014-03-13 | 2021-04-13 | Biotec Biológica Indústria Farmacêutica Ltda E.P.P | Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso |
WO2016008546A1 (en) * | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Aqueous formulation comprising paracetamol and ibuprofen |
CN104288099B (zh) * | 2014-09-25 | 2017-02-15 | 西安仁仁药业有限公司 | 一种布洛芬注射液的制备方法 |
MX2017012312A (es) * | 2015-03-27 | 2018-01-18 | Gruenenthal Gmbh | Formulacion estable para administracion parenteral de tapentadol. |
MX2017016276A (es) | 2015-06-18 | 2018-06-19 | Mithra Pharmaceuticals S A | Unidad de dosificacion orodispersable que contiene un componente estetrol. |
TN2017000497A1 (en) | 2015-06-18 | 2019-04-12 | Mithra Pharmaceuticals S A | Orodispersible dosage unit containing an estetrol component |
EP3120837A1 (de) | 2015-07-22 | 2017-01-25 | Stada Arzneimittel Ag | Verfahren zur herstellung einer bortezomibester-lösung |
JP2019506407A (ja) | 2016-02-05 | 2019-03-07 | イノファーマ インク | 酸化感受性製剤のための安定なすぐ使用できる注入バッグを製造するプロセス |
BR112019005439A2 (pt) | 2016-09-23 | 2019-06-18 | Gruenenthal Gmbh | formulação estável para administração parenteral de tapentadol |
CA3051467C (en) | 2017-01-30 | 2022-11-29 | Nevakar, Inc | Norepinephrine compositions and methods therefor |
WO2018192664A1 (en) * | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF |
WO2019150381A1 (en) * | 2018-02-01 | 2019-08-08 | Joshi Mahendra R | A stable pharmaceutical composition and process for production of isoproterenol hydrochloride injection |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
CR20200552A (es) | 2018-05-16 | 2021-05-13 | Bayer Healthcare Llc | Fórmula de suspención de alta concentración para medicamentos en cápsula de gel blanda paae resfriado y gripe |
JP2022514151A (ja) * | 2018-10-08 | 2022-02-10 | メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー | 神経毒プレフィルドバイアル |
US10478453B1 (en) | 2019-01-15 | 2019-11-19 | Exela Pharma Sciences, LLC | Stable, highly pure L-cysteine compositions for injection and methods of use |
CN113105040A (zh) * | 2021-04-02 | 2021-07-13 | 武汉工控工业技术研究院有限公司 | 一种自然水体无菌处理及长期保存技术 |
CN116803376B (zh) * | 2023-08-04 | 2024-02-13 | 广州白云山星群(药业)股份有限公司 | 一种复方愈创木酚磺酸钾口服溶液的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3443004A (en) * | 1965-04-08 | 1969-05-06 | Ciba Geigy Corp | Injectable solution containing 6-chloroor 6-trifluoromethyl-7-sulfamyl - 1,2,4-benzothiodiazine-1,1-dioxide diuretic |
DD153578A1 (de) * | 1980-10-22 | 1982-01-20 | Hans Meffert | Stabilisierung von oxydationsempfindlichen wirkstoffen,vorrangig dithranol in arzneizubereitungen |
RO93391B (ro) * | 1984-12-20 | 1988-03-31 | Eli Lilly And Company | Procedeu pentru prepararea unor saruri de dobutamina |
EP0619739A1 (en) * | 1992-10-21 | 1994-10-19 | Alcon Laboratories, Inc. | Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
AU5680994A (en) * | 1992-12-10 | 1994-07-04 | Abbott Laboratories | Stabilized catecholamine solutions |
FR2740338B1 (fr) * | 1995-12-01 | 1997-12-05 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees contenant de la dobutamine |
FR2751875B1 (fr) * | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
-
2000
- 2000-06-06 FR FR0007231A patent/FR2809619B1/fr not_active Expired - Lifetime
-
2001
- 2001-06-06 RU RU2003100090/15A patent/RU2003100090A/ru not_active Application Discontinuation
- 2001-06-06 DZ DZ013384A patent/DZ3384A1/xx active
- 2001-06-06 CZ CZ200313A patent/CZ200313A3/cs unknown
- 2001-06-06 US US10/332,060 patent/US6992218B2/en not_active Expired - Lifetime
- 2001-06-06 CA CA2415403A patent/CA2415403C/fr not_active Expired - Lifetime
- 2001-06-06 AU AU2001266120A patent/AU2001266120A1/en not_active Abandoned
- 2001-06-06 AP APAP/P/2002/002711A patent/AP1880A/en active
- 2001-06-06 CN CNA018136702A patent/CN1556694A/zh active Pending
- 2001-06-06 WO PCT/FR2001/001749 patent/WO2001093830A1/fr active IP Right Grant
- 2001-06-06 YU YU103A patent/YU103A/sh unknown
- 2001-06-06 NZ NZ523458A patent/NZ523458A/en not_active IP Right Cessation
- 2001-06-06 MX MXPA03000001A patent/MXPA03000001A/es active IP Right Grant
- 2001-07-16 PE PE2001000715A patent/PE20030508A1/es not_active Application Discontinuation
- 2001-07-31 TW TW090118576A patent/TWI237570B/zh not_active IP Right Cessation
-
2003
- 2003-01-03 MA MA26990A patent/MA26926A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
TWI237570B (en) | 2005-08-11 |
US20040054012A1 (en) | 2004-03-18 |
NZ523458A (en) | 2005-08-26 |
AP2002002711A0 (en) | 2002-12-31 |
CA2415403C (fr) | 2011-05-24 |
CA2415403A1 (fr) | 2001-12-13 |
CZ200313A3 (cs) | 2003-11-12 |
AU2001266120A1 (en) | 2001-12-17 |
US6992218B2 (en) | 2006-01-31 |
WO2001093830A1 (fr) | 2001-12-13 |
FR2809619A1 (fr) | 2001-12-07 |
MA26926A1 (fr) | 2004-12-20 |
MXPA03000001A (es) | 2004-03-19 |
DZ3384A1 (fr) | 2001-12-13 |
CN1556694A (zh) | 2004-12-22 |
PE20030508A1 (es) | 2003-06-25 |
AP1880A (en) | 2008-08-19 |
RU2003100090A (ru) | 2004-05-10 |
FR2809619B1 (fr) | 2004-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU103A (sh) | Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju | |
HRP20060089B1 (en) | Method for the stabilization of atorvastatin | |
ES2216965T5 (es) | Procedimiento de tratamiento y de extracción de compuestos orgánicos del corcho, mediante un fluido denso bajo presión | |
EP1082907A3 (en) | A sterilising method by substituting the dissolved oxygen in milk or the like with nitrogen gas, a product thereof and an apparatus for nitrogen gas substitution | |
ES2076646T3 (es) | Procedimiento para el llenado de botellas o de recipientes similares con un material liquido a envasar asi como un dispositivo para la realizacion de este procedimiento. | |
EP0780131A3 (en) | Method and apparatus for the application of volatile substances conveyed in carrier gas | |
AU2002234448A1 (en) | A method of processing roasted coffee | |
Scheffer | O2 requirements for growth and survival of wood-decaying and sapwood-staining fungi | |
WO2005020706A3 (en) | Wine preservation system using a central vacuum | |
ATE176577T1 (de) | Konservierungsmittel | |
TNSN05029A1 (en) | Cork product treatment system and apparatuses by extraction of compounds dragged in water vapour | |
IT1201997B (it) | Procedimento per la sanitizzazione di contenitori e materiali di confezionamento, particolarmente per uso farmaceutico e cosmetico, ed impianto per effettuare il procedimento | |
WO2003037388A3 (en) | System and method for de-contaminating and/or sanitizing | |
EP0294165A3 (en) | Fresh fish package and method for processing fresh fish | |
WO2005044315B1 (en) | Method for sterilization using ethylene oxide | |
IL139465A0 (en) | Method for prolonged storage of dna molecules and packaging implementing said method | |
CA2789379A1 (en) | Method of packaging fresh meat products in a low oxygen environment, meat color improvement solution and pre-packaged food product | |
DK0591852T3 (da) | Produkt med nedsat H2S-indhold og fremgangsmåde til fremstilling deraf | |
WO2007098350A3 (en) | Method and apparatus for killing insects on fresh produce | |
SE9402119D0 (sv) | Solution | |
WO2008054198A3 (en) | Packaging and method for storing of living crustaceans and shellfish | |
EP1099977A3 (en) | Preparation method of photothermographic material | |
JPS5779847A (en) | Penetration of effective food into food | |
KR200400408Y1 (ko) | 살균 및 제독기능과 맛을 향상시키는 병뚜껑 | |
ES2958166B2 (es) | Método de tratamiento con agua activada por plasma de materiales auxiliares de origen forestal para la conservación del vino y uso del agua activada por plasma |